Signaling pathways in the biphasic effect of angiotensin II on apical Na/H antiport activity in proximal tubule  by Houillier, Pascal et al.
Kidney International, Vol. 50 (1996), Pp. 1496—1505
Signaling pathways in the biphasic effect of angiotensin II on
apical Na/H antiport activity in proximal tubule
PASCAL H0uILLIER, REGINE CHAMBREY, JEAN MICHEL ACHARD, M&ic FROISSART, J0sIANE PoGGIou,
and MICHEL PAILLARD
Département de Physiologic, Université Pierre et Marie Curie, Institut National de Ia Sante et de la Recherche Médicale Unite 356, Hôpital Broussais,
Paris, France; and Departments of Medicine and Physiology & Biophysics, and Nephrology Research and Training Center, University of Alabama at
Birmingham, Birmingham, Alabama, USA
Signaling pathways in the biphasic effect of angiotensin II on apical
Na/H antiport activity in proximal tubule. Low concentrations of anglo-
tensin II (Ang II) increase, whereas high concentrations inhibit the apical
Na/H antiporter activity in the proximal tubule, but the respective roles of
the different signaling pathways in mediating these effects remains unset-
tled. We studied the effects of both low and high doses of Ang II in the
presence of selective signaling pathway inhibitors, on the apical Na/H
antiport activity of rat proximal tubule. Experiments were carried out in
intact cells of freshly prepared tubule fragments obtained from the outer
third of cortex, that is, devoid of basolateral Na/H antiport activity in the
absence of bicarbonate transport and H-ATPase activity. In tubules
acid-loaded by an NH4C1 prepulse, Na/H antiport activity was assessed by
the initial rate of intracellular pH recovery (dpHi/dt), measured with
BCECF. When tubules were preincubated with low dose Ang II (10h1 M
for 3 mm), dpHi/dt increased by 25 8%, whereas incubation with high
dose Ang II (10 M for 3 mm) decreased dpHi/dt by 30 4%, compared
to control (P < 0.01 in both cases). Both effects were abolished in the
presence of 2.10 M amiloride. Low dose Ang TI-induced increase in
dpHi/dt was not affected by preincubation with a specific PKA inhibitor,
Rp-CPT-cAMP i0' M, and was completely abolished by preincubation
with PKC inhibitors, staurosporine i0 M, sphingosine 5.10 M, or
calphostin 10 M. In addition, pretreatment of rats with pertussis toxin
led to a partial inhibition of the effect of low dose Mg II. The high
dose-Mg It-induced decrease in dpHi/dt was not affected by pretreatment
with a calcium-calmodulin kinase inhibitor W-7 iO M. Conversely,
pretreatment with the cytochrome P-450 inhibitor econazole 10 M
reversed the inhibitory effect of high dose Aug II to a stimulatory effect
(24 8%, P < 0.01), quantitatively similar to the effect of low dose Aug
II. In addition, arachidonate was found to exert an econazole-sensitive
dose-dependent inhibitory effect on dpHi/dt, and 5,6-EET 10_6 M, a
cytochrome P-450 derived-arachidonic acid metabolite, induced a 38
9% inhibition, similar to that observed with high dose Mg II alone. There
was no additive effect of 5,6-EET and high dose Ang II. Finally,
pretreatment with two PLA2 inhibitors (BromoPhenacyiBromide, 6.10
M, and oleyloxyethyl phosphoiylcholine, 5.106 M) reversed the inhibitory
effect of high dose Mg II to a stimulatory effect (32 11% and 25 11%,
respectively, P < 0.05 for both inhibitors). We conclude that, in intact rat
proximal cells, low dose Mg II stimulates the apical Na/H antiport
through a pertussis toxin-sensitive G protein-dependent PKC pathway,
whereas high dose Ang II inhibits the Na/H antiport activity through the'\
PLA2- and cytochrome P-450-dependent metabolites of arachidonate.
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The apical membrane Na/H antiport activity mediates approx-
imately two-thirds of NaHCO3 absorption and 100% of transcel-
lular NaCl absorption in the proximal tubule. A dose-dependent
biphasic effect of angiotensin II (Ang II) on NaCI, bicarbonate
and water absorption in the proximal tubule has been repeatedly
reported [1—3]: low concentrations stimulate and high concentra-
tions inhibit proximal tubular transports. Regarding the identifi-
cation of the signaling factors involved in the biphasic effect of
Ang II on the apical Na/H antiport of the proximal tubule, the
available information remains unclear.
In in vivo microperfusion experiments in rat proximal tubule,
low circulating concentrations of Ang II, which enhance bicarbon-
ate absorption, are associated with a decrease in tubular fluid
cyclic AMP delivery, and luminal perfusion with dibutyryl cyclic
AMP to clamp intracellular cyclic AMP abolishes the effect of
Ang II [4]. In addition, the effect of low circulating concentrations
of Ang II is attenuated by pretreatment of rats with pertussis toxin
[4]. These experiments suggest that the effects observed may occur
via PKA inhibition. However, no study testing the effect of PKA
inhibition in the Mg TI-induced increase in bicarbonate absorp-
tion is available. In addition, in opposum (OK) cell lines, the Mg
IT-induced increase in Na/H antiport activity is cyclic AMP-
independent [5]. Moreover, in in vivo experiments in rat proximal
tubule, the increment in solute and water absorption induced by
low dose of Aug II is partly or completely inhibited by PKC
inhibitors (sphingosine and H-7) [6, 7], which suggests that PKC
may be involved in the effects of Ang II. However, these PKC
inhibitors are relatively nonspecific [8]. It is confusing that in
rabbit proximal tubule cells in culture Ang II is not able to
stimulate inositol phosphate (IPs) production [9].
The inhibitory effect of high doses of Ang II on HC03
absorption in proximal tubule may be mimicked by the calcium
ionophore ionomycin and suppressed by 3,4,5-trimethoxybenzoic
acid 8-(diethylamino) octyl ester (TMB-8) used as a blocker of
intracellular Ca2 mobilization [7, 10]. The results led to the
proposal that high concentrations of Ang II may reduce proximal
tubular transports through an increase in cytosolic Ca2, in
agreement with the finding that calcium-calmodulin-dependent
kinase (Ca-CaM-K) directly inhibits the activity of the reconsti-
tuted Na/H antiporter [111. Finally, in rabbit proximal cells in
culture, the inhibitory effect of high doses of Mg II on the apical
Na/H antiporter is suppressed by ketoconazole which is an
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Table 1. Composition (in mM) of the various solutions used in the
study
A B C D E F G H
TMAC1 — — — — — 140 140 —
NaCI 115 140 120 120 140 — — 115
NaHCO3 25 — — — — — 25
NH4CI — — 20 20 — — — —
HEPES — 10 10 10 10 10 10 10
Na2HPO4 0.3 — — — — — — —
KH2PO4 0.4 0.2 0.2 — — 0.2 — 0.2
K2HPO4 — 0.8 0.8 — — 0.8 — 0.8
MgSO4 0.4 1 1 — — 1 — 1
MgCl2 0.5 — 1 1 — I —
CaC12 1 1 1 1 1 1 1 1
KCI 5.4 3 3 4.8 4.8 3 4.8 3
Glucose 5 5 5 — — 5 — 5
Alanine 5 5 5 — — 5 — 5
ATP — 0.25 — — — — — 0.25
GTP — 0.25 — — — — — 0.25
inhibitor of P-450 epoxygenase [121. This result is in agreement
with the inhibitory effect of 5,6-EET on the Na/H antiporter
observed in this preparation.
These conflicting observations may result from species (rat vs.
rabbit) or experimental differences (in vitro vs. in vivo experiments
where other hormones or neurotransmitters may be involved,
intact vs. cultured cells). Recent studies from our laboratory using
freshly isolated proximal tubule fragments have shown that Ang II
reduces cyclic AMP production and also stimulates inositol phos-
phate production with a concomitant rise in cytosolic Ca2 mainly
due to mobilization of cellular stores [13]. These effects are time
and concentration-dependent and are coupled with AT1 receptor
subtypes. The aim of the present study was to test in this
preparation of rat intact proximal tubule cells, first the role of
PKA inhibition and PKC activation in the Ang Il-induced stimu-
lation of the apical Na/H antiport, and second the role of
Ca-CaM-K and the epoxygenase-derived metabolites of arachi-
donate in the inhibitory effect of Ang II.
Methods
Tubule isolation
Renal proximal tubules were prepared from 250 to 300 g male
Sprague-Dawley rats allowed free access to regular rat chow and
tap water until anesthetized with pentoharbital sodium. The
kidneys were perfused in situ with saline (9 g NaCl/liter) contain-
ing 0.5% (wt/vol) magnetic iron oxide as previously described [13,
14]. The kidneys were removed and the outer third of the cortex
separated and cut into pieces. Collagenase digestion (0.5 mg/mI)
was performed by four 10-minute treatment periods at 37°C in
Hanks' solution (Solution A, Table 1) containing 0.1% bovine
serum albumin (BSA) and bubbled with 95% 02-5% CO2. After
each period, supernatants containing tubule fragments were col-
lected after one-minute gravity sedimentation and stored on icc.
After the last digestion, these supernatants were sieved through
75-p.m opening nylon mesh, harvested with solution A containing
1% BSA, and centrifuged (1 mm, 50 g, 4°C). The suspension was
washed once by centrifugation (1 mm, so g, 4°C) and resuspended
in the solution A under an atmosphere of 95% 02-5% CO2 before
magnetic separation of the glomeruli. Tubular segments were of
high viability (> 95% excluded trypan blue) and contained <2%
glomeruli, as previously reported [13].
Measurement of intracellular pH
All experiments in the study were carried out in C02/bicarbon-
ate-free media. To load proximal tubules cells with the pH-
sensitive probe BCECF, tubule suspensions were incubated for 30
to 45 minutes at 37°C in a bicarbonate-free medium (solution B)
containing 0.1% BSA and 0.012 mvi BCECF-acetoxymethyl ester
[BCECF-AM, dissolved in dimethylsulfoxide (DMSO) and stored
at —20°C], and adjusted at pH 7.40 with Tris. Two different ways
of intracellular acidification were used in this study.
Acidification by nigericin of Na-depleted cells
In a set of experiments specifically designed to assess the
functional characteristics of the Na/H antiporters present in the
preparation, the BCECF-loaded tubules were washed five times
by gentle centrifugation in a Na-free medium (solution F) and
resuspended in the same solution containing 0.1% BSA, and
adjusted at pH 7.40 with Tris. Aliquots of the tubule suspension
were subsequently incubated at 37°C in the latter medium,
together with i0— M ouabain for three minutes in order to
prevent Na transport out of the cells during the measurement of
Na/H antiport activity. Afterwards, nigericin (10 p.M) were added
to the aliquot. After one minute, the tubules were washed with 1%
(wt/vol) BSA in Na-free solution and was pelleted by gentle
centrifugation (1 mm, 50 g, 37°C) The supernatant was discarded,
and the tubules were resuspended in 100 p.1 of the latter medium
and diluted into glass cuvettes containing 2.5 ml of a Na-free
medium (solution G) to reach a final cytocrit of —1 vol%c. For
each aliquot, the medium contained 200 nivi bafilomycin Al, in
order to inhibit any H-ATPase activity [15], iO M ouabain, and
2 p.M of H0E694 or vehicle. After a one minute recording, NaC1
was added into the cuvette to reach a final Na concentration of 10
mM.
Acidification by a NH4 prepulse
In most experiments in this study, tubular cells were acidified by
a NH4 prepulse. The BCECF-loaded tubules were washed four
times by gentle centrifugation to remove the cxtracellular dye and
resuspended in solution C containing 0.1% BSA, and adjusted at
pH 7.40 with Tris. Aliquots of the tubule suspension were
subsequently incubated at 37°C in the latter medium, together
with the appropriate concentration of Ang 11 and/or signaling
pathway inhibitors (see below). After the completion of treat-
ment, each aliquot was rinced once in solution D adjusted at pH
7.40 with Tris, and was pelleted by gentle centrifugation (1 mm,
50 g, 37°C). The supernatant was discarded, and the tubules were
resuspended in 100 p.1 of the latter medium and diluted into glass
cuvettes containing 2.5 ml of the solution E to reach a final
cytocrit of —1 vol%c. For each aliquot, the medium contained 200
nM bafilomycin Al, in order to inhibit any H-ATPase activity
[15], and the same concentration of Ang II and/or signaling
pathway inhibitor as the treatment medium. Acute intracellular
acidification was obtained by incubating the tubules in a medium
containing 20 ms'i NH4C1 (solutions C, and D), and resuspending
in a NH4CI-free solution (solution E).
BCECF fluorescence was monitored by use of a Shimadzu
model RF-5000 spectrofluorometer (Shimadzu Corporation,
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Kyoto, Japan) equipped with a water-jacketed, temperature con-
trolled cuvette holder, and a magnetic stirrer. All experiments in
the present work were performed at 37°C. Fluorescence intensity
was recorded at one emission wavelength, 525 nm, whereas the
excitation wavelength alternated automatically at 2 second inter-
vals between 500 and 450 nm. The values of the fluorescence ratio
F 500/F 450 were converted into pHi values with use of calibration
curves. Calibration curves were established twice on each exper-
iment, on two samples of the tubules suspension. The relationship
between intracellular BCECF fluorescence and pHi was deter-
mined under conditions during which pHi and extracellular pH
may be assumed to be equal, that is, by placing the cells in medium
containing 120 m potassium and 3.3 jx of the K/H ionophore,
nigericin. The initial rate of pHi recovery (dpHi/dt) was calculated
by a computer-assisted fitting of the first 12 seconds of the time
course of pHi recovery to a linear equation. Correlation coeffi-
cients for these linear fits averaged 0.98 0.01.
cAMP determination
The method for measurement of cAMP production by the
tubules has been previously described [13]. Tubules were incu-
bated in a Ringer's solution (solution H) containing 1 mvi
isobutylmethyixantine (IBMX) for 10 minutes, after which 0.3 ml
samples of this suspension were withdrawn and transferred to
prewarmed tubes containing 3 pl of hormone or vehicle. After
four minutes the reaction was stopped by addition of 33 jxl HCIO4
(50%) and quickly centrifuged (1000 g, 15 mm, 4°C). The
supernatant containing cAMP was neutralized with saturated
K2C03. The production of cAMP by the tubules was determined
by radioimmunoassay (Amersham) after deproteinization of the
samples. When the effect of pertussis toxin was studied, animals
were prepared three to four days before study by the injection of
pertussis toxin (20 jxg/kg body wt) according to published proto-
cols [13, 16, 17].
Materials
Collagenase was obtained from Boehringer Mannheim France
(Meylan, France), BCECF-AM from Molecular Probe (Eugene,
OR, USA). Oleyloxyethyl phosphorylcholine, BromoPhenacil
bromide, and 5,6-EET were purchased from BioMol. Rp-8-(4-
chlorophenylthio)-cAMP (Rp-8-CPT cAMP) was from Biolog.
Pertussis toxin was from List Biological Laboratories. Nigericmn,
8-bromoadenosine 3':S'-cyclic monophosphate, trifluoperazine,
N-(6-aminohexyl)-5-chloro-1-naphtalenesulfonamide (W-7), stau-
rosporine, sphingosine, caiphostin, econazole, arachidonic acid,
amiloride, alanine, and Ang II were purchased from Sigma
Chemical Co. (St. Louis, MO, USA). The nonpeptide antagonist,
losartan potassium, was provided by Dr. R.D. Smith from DuPont
(Wilmington, DE, USA). Bafilomycin Al was donated by Prof.
K. Altendorf (Universitat OsnabrUck, Germany), and (3-methyl-
sulphonyl-4-piperidinobenzoyl) guanidine methanesulphonate(H0E694) was a gift from Prof. J. Pouysségur (Université dc
Nice-Sophia Antipolis, France).
Statistics
Results are mean SE. In each group, N refers to the number
of measurements. Statistical significance between experimental
groups was assessed by one-way or two-ways analysis of variance,
completed by t-test and Bonferroni method for multiple compar-
isons.
I I I I
—20 0 20 40 60
Time, seconds
Fig. 1. Effect of 2 JxM of Na-H antiporter inhibitor HOE 694 on the rate of
recovery of intracellular pH in nigericin-acidified, Na-depleted proximal
tubular cells. Intracellular pH was recorded for 30 seconds before and 60
seconds after acute Na addition (final concentration 10 mM). Intracellular
pH recovery was identical in HOE 694-treated cells (•; N = 9; dpHi/dt =
0.439 0.089 UpH/min) and control cells (0; N = 11; 0.438 0.073
UpH/min).
Results
Only apical Na/H antiport activity was present in the preparation
These experiments have been carried out in Na-depleted,
nigericin-aeidified proximal tubular cells. The time course of
intracellular pH of acidified cells in a Na-free medium and the
rate of intracellular pH recovery after addition of 10 m Na, in
the absence or presence of 2 xM H0E694, is shown in Figure 1.
No pH recovery was observed in Na-free medium, indicating that
the pH recovery was entirely a sodium-dependent process. Sec-
ond, 2 M H0E694, which inhibits the NHEI isoform by -90%
whereas the other NHE isoforms are either not affected or
marginally inhibited [18], did not affect the rate of pH recovery
induced by the addition of Na. These results indicate that, in the
suspension of superficial proximal tubules studied, there is, on a
functional basis, no NHE1 isoform (the basolateral antiporter).
All the following experiments were conducted in proximal
tubular cells acidified by NH4 prepulse in the presence of 140 mto
external Na. Amiloride (2.10 M, 3 mm preineubation) induced a
striking decrease (84%) in the initial rate of pH recovery as
compared to control conditions [0.067 0.011 (N 10) versus
0.422 0.042 (N = 6) UpH/min, in the presence and absence of
amiloride, respectively, P < 0.0011, despite a more marked acute
intracellular acidification in the presence (6.78 0.01 UpH) than
in the absence of amiloride (6.88 0.02, P < 0.001). Thus,
amiloride induced a marked inhibition of the rate of pHi recovery.
A significant bicarbonate transport contributing to the acute
changes in pHi could he ruled out because all the experiments
were conducted in the absence of the C02/HC01 buffer system
Na 10mM
7.1
7.0
6.9
6.8
6.7 —
—40
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and that pHi recovery was not affected by the presence of 10 M
SITS (not shown).
Taken together, these results indicate that the recovery of
intracellular pH after a cellular acidification was mediated by a
Na-dependent process sensitive to amiloride, that is, the apical
Na/H antiporter(s). Therefore, dpHi/dt was taken as an estimate
of the apical Na/H antiport activity
Low dose Ang II stimulates and high dose Ang II inhibits apical
Na/H antiport activity
The addition of low dose-Ang 11(10 M, 3 mm preincubation)
induced a 25 8% increase in dpHi/dt as compared with control
conditions (P < 0.01; Fig. 2A). This effect was completely blunted
in the presence of amiloride (2.10 M, 3 mm preincubation)
[0.073 0.004 (N = 6) versus 0.067 0.011 (N = 10) UpH/min
for Ang II + amiloride, and amiloride, respectively]. Conversely,
the addition of high dose Ang II (10—v M, 3 mm preincubation)
decreased dpHi/dt by 30 4%, as compared to control conditions
(P < 0.01; Fig. 2B). The addition of amiloride (2.10 M) to the
tubule suspension, prevented the effects of Ang II [0.080 0.005
(N = 6) versus 0.067 0.011 (N = 10) UpH/min for Ang II +
amiloride, and amiloride, respectively]. This indicates that Ang II
affects the amiloride-sensitive Na/H antiporter(s). In addition,
when losartan 10 M was added to the suspension immediately
before low dose Ang II, the stimulation of pHi recovery was
totally abolished, whereas losartanperse had no effect on dpHi/dt
(0.360 0.025, N = 7; 0.470 0.025, N = 9; 0.355 0.050, N =
5; and 0.350 0.050, N = 10, UpH/min, for controls, Ang II,
losartan and Ang II + losartan, respectively). Taken together,
these results indicate that Ang II has a biphasic effect on the rate
of recovery of intracellular pH, and acts through the AT1 receptor
subtypes.
Ang 11-induced stimulation of the apical Na/H antiport activity is
not reduced by protein kinase A inhibition
Treatment of tubules with i0— M Rp-8-CPT-cAMP (a selective
and competitive inhibitor of P1(A) for 30 seconds before addition
of low dose Ang II did not affect the stimulating effect of low dose
Ang II on the apical Na/H antiport activity, and Rp-8-CPT-cAMP
alone had no effect (Table 2). To be sure that Rp-8-CPT-cAMP
actually inhibited protein kinase A, we carried out experiments on
the effect of forskolin (10 M) on dpHi/dt in the presence and
absence of iO- M Rp-8-CPT-cAMP. Treatment for two minutes
with forskolin alone clearly inhibited the apical Na/H antiport
activity (0.248 0.023 vs. 0.380 0.044 UpH/min for forskolin
and control, respectively, P < 0.02, N 8 in each group). This
inhibitory effect was completely blunted when tubules were
treated with Rp-8-CPT-cAMP for 30 seconds before addition of
forskolin (0.376 0.012 IJpH/min,N = 8), thereby demonstrating
that Rp-8-CPT-cAMP efficiently inhibits the forskolin-induced
decrease in Na/H antiporter activity. In addition, the positive
effect of forskolin in the absence of Rp-8-CPT-cAMP establishes
that protein kinase A was normally efficient in our preparation.
Ang 11-induced stimulation of the apical Na/H antiport activity is
abolished by PKC inhibitors
Treatment of tubules with 10 M staurosporinc for eight
minutes prior to addition of 10_11 M Ang Tiled to a complete
suppression of the stimulating effect of Ang IT, whereas stauro-
A
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Fig. 2. A. Efect of low-dose Ang II (1(1 " M) on the initial rate of recove.'y of
intracellular pH. Absolute values were 0.336 0.024, and 0.420 0.024
UpH/min for controls, and Ang TI, respectively. Initial pH were 6.92 0.02,
and 6.93 0.02 for controls, and Ang IT, respectively (NS). Ang TI induced a
25% increase in dpHi/dt (P < 0.01). Symbols are: (0) controls, N = 14; (S)
Aig TI, 10h1 M, N = 14. B. Effect of high dose Ang 11(10 M) on the initial
rate of recovery of intracellular pH. Absolute values were 0.396 0.030, and
0.276 0.012 UpH/min for controls (0) and Ang TI (•), respectively. tnitial
pH were 6.96 0.01, and 6.91 0.02 for controls, and Ang IT, respectively
(NS). Ang II induced a 30% decrease in dpHi/dt (P < 0.01).
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Table 2. Effect of protein kinase A inhibitor Rp-CPT-cAMP (10- M)
on the low dose (iO_IJ M) Ang Il-induced increase in dpHi/dt
N Initial pH
dpHi/dt
UpH/min
Ang 11 induced-
change in dpHi/dt
Control 7 6.78 0.01 0.376 0.008
Ang 11 7 6.80 0.01 0.462 0.016" 23%
Rp-CPT-cAMP
Rp-CPT-cAMP
7
7
6.79 0.02
6.80 0.02
0.358 0.012
0.470 0.01 6l 31%
+ Ang II
Fig. 3. A. Effect of protein kinase C inhibitor staurosporine (1O M) on the
low dose Ang 11-induced increase in dpHi/dt. Results are expressed as
percent (± Sc) of control values. Absolute values were 0.336 0.042,
0.437 0.042, 0.354 0.053, and 0.317 0.046 UpH/min for controls,
Ang 11, staurosporine and Ang II + staurosporine, respectively. Initial pH
were 6.80 0.04, 6.86 0.05, 6.78 0.03, and 6.79 0.04 for controls,
Aug II, staurosporine and Aug II + staurosporine, respectively (NS for all
comparisons). Staurosporine did not display any own effect, but led to a
complete inhibition of the stimulating effect of low-dose Aug 11. B. Effect
of protein kinase C inhibitor sphingosine (5.10—6 M) on the low dose Ang
Il-induced increase in dpHi/dt. Results are expressed as percent (± SE) of
control values. Absolute values were 0.288 0.03 1, 0.364 0.031,0.324
0.047, and 0.304 0.046 UpH/min for controls, Aug II, sphiugosine and
Aug II + sphingosiuc, respectively. Initial pH were 6.97 0.03, 6.97
0.02, 6.95 0.03, and 6.94 0.03 for controls, Aug 11, sphingosine and
Aug II + sphingosine, respectively (NS for all comparisons). Sphiugosine
did not display any own effect, but led to a complete inhibition of the
stimulating effect of low dose Aug II. C. Effect of protein kinase C
inhibitor calphostin (l0' ci) on the low dose Aug lI-induced increase in
dpHi/dt. Results arc expressed as percent (± Sc) of control values.
Absolute values were 0.266 0.021, 0.360 0.005, 0.275 0.018, and
0.267 0.03 1 UpH/min for controls, Aug 11, calphostin and Aug 11 -f
calphostin, respectively. Initial pH were 6.79 0.05, 6.78 0.03, 6.78
0.03, and 6.77 0.02 for controls, Aug II, calphostiu and Aug TT +
calphostin, respectively (NS for all comparisons). Calphostin did not
display any own effect, hut led to a complete inhibition of the stimulating
effect of low-dose Aug II.
Control Aug I Caiphostin Calphostin
N=5 10 M N=6 Ang II
N=5 N=6
A
+ 30% P<0.05 NSII
"P < 0.001 vs. control
6? < 0.001 vs. Rp-CPT-eAMP
sporine alone had no effect (Fig. 3A). Treatment of tubules with
5.106 ci sphingosine for 10 minutes prior to addition of 10'' M
Ang II totally abolished, as did staurosporine, the effect of Ang II.
In addition, sphingosine alone did not induce any change in the
rate of recovery of intracellular pH (Fig. 3B). Treatment of
tubules with 10 M calphostin for 10 minutes prior to addition of
10 ci Ang II totally abolished the effect of Ang II, as did
staurosporine and sphingosine; in addition, caiphostin alone did
not induce any change in the rate of recovery of intracellular pH
(Fig. 3C). Thus, treatment with three different PKC inhibitors led
to the same result, that is, a complete inhibition of the stimulating
effect of low dose Ang II on the Na/H antiport activity.
PKC-dependent Ang 11-induced stimulation of apical Na/H
antiport activity is pert ussis toxin-sensitive
Pretreatment of rats by pertussis toxin (20 xg/kg body wt
intravenously, 3 to 4 days prior to experiments) did not induce any
change in the rate of recovery of intracellular pH as compared to
control rats. Treatment of tubules by 10h1 M Aug TIled to an
increase in dpHi/dt of 12 5%, P < 0.05, when tubules were
obtained from rats treated by pertussis toxin, and of 25 6%, P <
0.01, when tubules were obtained from control rats (Fig. 4A).
Control Ang II Stauro. Stauro.+
N=13 1011M N=15 AngIl
N=14 N=15
B
+ 26% P<0.05
T
NS
150
00
0
100
I
a-
-a
50
150
00
0
100
-DI
a-
-a
50
150
00
'I-0
100
-aI
a-
50
Control Ang II
N=11 101M
N=1 2
C
Sphingosine Sphingosine
N=8 Ang Il
N=9
+ 35% P<0.05 NS
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Control Ang II
N=12 10°M
P4=1 2
Fig. 4. A. Effect of perfussis toxin (PT; 20 xg/kg body wt, 3 to 4 days heft)re
experiments) on the low dose-Ang 11-induced increase in dpHi/dI. Results are
expressed as percent (± SE) of control values. Absolute values were
0.279 0.012, 0.348 0.018, 0.282 0.012, and 0.315 0.012 UpH/min
for controls, Ang II, pertussis toxin, and pertussis toxin + Ang II,
respectively. Initial pH were 6.74 0.03, 6.77 0.01, 6.72 0.02, and
6.72 0.01 for controls, Ang II, pertussis toxin, and pertussis toxin + Ang
IT, respectively (NS for all comparisons). Pertussis toxin per se did not
exert any own effect, but decreased by 53% the Ang TI-induced increase in
dpHi/dt (P < 0.01). B. Effect of combined pertussis toxin and staurospor-
me (l0- M) on the low dose-Ang Il-induced increase in dpHi/dt. Results
are expressed as percent (± SE) of control values. Absolute values were
0.308 0.026, 0.386 0.017, 0.298 0.005 and 0.298 0.006 UpH/min,
for controls, Ang II, pertussis toxin + staurosporine, and pertussis toxin +
staurosporine + Ang 11, respectively. Initial pH were 6.75 0.03, 6.78
0.02, 674 0.03, and 6.74 0.02 for controls, Ang II, pertussis toxin +
staurosporine, and pertussis toxin + staurosporinc -- Ang II, respectively
(NS for all comparisons).
Table 3. Effect of calcium-calmodulin kinase inhibitor W-7 (10—a M) on
the high dose (10-v M) Ang IT-induced decrease in dpHi/dt
Ang II
induced-
dpHi/dt change
N Initial pH UpH/min in dpHi/dt
Control 7 6.94 0.02 0.370 0.040
Ang II
W-7
9
8
6.88 0.02
7.01 0.03"
0.210 0.040"
0.550 0.071"
43%
W-7 + Ang II 9 6.97 0.03 0.271 0.059" —51%
Thus, treatment by pertussis toxin led to a partial inhibition of the
effect of low dose Ang II on the Na/H antiporter (—53 16%,
P < 0.01). In addition, in tubules obtained from pertussis toxin-
treated rats and incubated with the PKC inhibitor staurosporine
(10—v M, for 8 mm prior to addition of Ang II), the effect of Ang
II on dpHi/dt was completely abolished as with the PKC inhibitor
alone (Fig. 4B). These results suggest that a pertussis toxin-
sensitive signal mediated in part the effect of low dose Ang II
through PKC pathway. To assess the efficiency of the pretreat-
ment with pertussis toxin in our preparation, we examined the
effect of Ang II on the cAMP production of tubules obtained
either from control or pertussis toxin-treated rats. Because, even
in the presence of IBMX, the basal cAMP production was low and
its inhibition by Ang II of small magnitude [13], we studied the
effect of iO— M Ang II (a concentration at which the maximal
inhibitory effect on cAMP production had been observed [13])
and pertussis toxin on forskolin (10—6 M)-stimulated cAMP accu-
mulation. In control rats, Ang II induced a decrease in cAMP
accumulation, as compared with forskolin alone [42 2 (N = 18)
versus 50 2 (N = 19) fmol/,irg protein/four minutes, P < 0.01].
In pertussis toxin-treated rats, Ang II did not further affect cAMP
accumulation as compared with forskolin [53 2 (N = 8) versus50 2 (N = 8) fmol/xg protein/four minutes, P = NS].
Ang Il-induced inhibition of the apical Na/H antiport activity is
not suppressed by calcium-calmodulin-dependent kinase inhibitors
Treatment of tubules with i(Y s4 trifluoperazine (TFP) or iO
M W-7 for six minutes led to an increase in dpHi/dt of 31 15%
[0.456 0.042 (N = 8) vs. 0.348 0.048 (N = 7) UpH/min, P <
0.05] and 49 18% [0.550 0.071 (N = 8) versus 0.370 0.040(N = 7) UpH/min, P < 0.01], respectively, as compared with
controls). However, high dose Ang 11 induced a similar decrease
in dpHi/dt whether tubules were incubated with W-7 (—51 7%
vs. W-7 alone, P < 0.01) or not (—43 9% vs. control, P < 0.01;
Table 3). Thus, despite its own stimulatory effect on the basal
activity of the apical Na/H antiport activity, W-7 did not affect the
inhibitory effect of high dose-Ang IT on the antiport activity.
Moreover, since one study in the mouse has suggested that low
dose Ang II stimulates luminal acidification in the proximal tubule
in vitro through a calcium calmodulin-dependent mechanism [19],
we tested the effect of TFP and W-7 on the low dose effect of Ang
II. Low dose Ang TI induced a similar increase in dpHi/dt, whether
tubules were incubated with W-7 (20 8% vs. W-7 alone, P <
0.05) or not (21 9% vs. control, P < 0.05; Table 4). The same
results were obtained with TFP and Ang II (Table 4).
— 53%, P'zO.Ol
+ 25%, P<0.0l + 12%, P<0.05
I I
"P < 0.05 vs. Ang II
"P < 0.01 vs. control
P < 0.01 vs. W-7
A
150
0()
.4..-0
1 100
DI
50
150 —
0
c.)
100 -.
I0.0
50 —
B
Control Ang II PT PT
N=7 1011M N=8 +Angll
N=8 N=8
+ 25%, P<0.05 NS
PT+ P1+
Staurosporine Staurosporine+
N=12 Angil
N=12
1502 Houillier et al: Ang II and proximal Na/H antiport signaling
Table 4. Effect of calcium-calmodulin kinase inhibitors Trifluoperazine
and W-7 on the low dose Ang IT-induced increase in dpHi/dt
Ang II
induced-
dpHi/dt change in
N Initial_pH UpH/min dpHi/dt
Trifluoperazine i0 M
Control 7 6.94 0.05 0.348 0.048
Ang TI 7 6.96 0.06 0.438 0.054a 26%
Trifluoperazine 8 7.03 0.02 0.456 0.042
Trifluoperazine + 7 7.04 0.03 0.582 0.054k' 28%
Ang IT
W-7 lO- M
Control 10 6.72 0.03 0.600 0.042
Ang II 13 6.72 0.03 0.726 0.054c 21%
W-7 15 6.74 0.02 0.708 0.048c
W-7 + Ang II 12 6.76 0.03 0.852 0060d 20%
a P < 0.05 vs. control
< 0.05 vs. Trifluoperazinc
P < 0.05 vs. control
d P < 0.05 vs. W-7
Ang lI-induced inhibition of the apical Na/H antiport activity is
suppressed by inhibition of the production of cytochrome P450-
epoxygenase-dependent metaholites of arachidonate
When tubules were treated by I o- M econazole (an inhibitor of
cytochrome P450 epoxygenase) for two minutes prior to the
addition of high dose Ang II, the inhibitory effect effect of Ang II
was reversed, and there was a stimulation of dpHi/dt of the same
magnitude that the one observed with low dose Ang 11(24 8%,
P < 0.01; Fig. 5). Thus econazole not only suppressed the
inhibitory effect of high dose Ang II, but restored the stimulatory
effect of Ang TI on the apical Na/H antiport activity. A nonspecific
effect of econazole, such as a decrease in Ang II binding, to
explain the reversed effect of high dose Ang IT by the inhibitor,
may be ruled out. Indeed, in the presence of low dose of Ang II,
dpHi/dt was equally increased, whether tubules were incubated
with econazole (0.366 0.037 vs. 0.288 0.024 UpH/min, for
Ang II + econazole and econazole, respectively, 27 12% vs.
econazole alone, P < 0.05) or not (0.366 0.035 vs. 0.282 0.034
UpH/min, for Aug H and control, respectively, 30 14% vs.
control, P < 0.005). If econazole blocked the production of
arachidonate metabolites dependent of cytochrome P450-epoxy-
genase, arachidonate and its metabolites should be expected to
inhibit the basal Na/H antiport activity. Indeed, arachidonate (3
mm preincubation) decreased dpHi/dt in a dose-dependent man-
ner (Fig. 6) with a maximum effect reached at 10 M (—31 6%,
P < 0.01). When tubules were pretreated for two minutes with
econazole (10 M), i0 M arachidonate did not exhibit its
inhibitory effect on the apical Na/H antiport activity (Fig. 6),
which indicates that the arachidonate effect was mediated through
its cytochrome P-450 metabolites. Finally, we tested the effect of
5,6-EET, an epoxide preferentially produced by the rat proximal
tubule cells 1201. When tubules were incubated for three minutes
with 10 6 M 5,6-EET, dpHi/dt was clearly decreased as compared
to control condition (—30 8%, P < 0.05), and the decrease was
similar to that observed with high dose Ang 11. In addition, there
were no additive effects of 5,6-EET and iO M Ang 11, suggesting
that 5,6-EET is the main epoxide involved in the inhibitory effect
of Ang II (Fig. 7).
Fig. 5. Effect of cytochrome P-450 inhibitor econazole (]0 si) on the high
dose Ang lI-induced decrease in dpHi/dt. Results are expressed as percent
(± SE) of control values. Absolute values were 0.416 0.037, 0.291
0.045, 0.355 0.029, and 0.439 0.021 UpH/min for controls, Aug II,
cconazole, and econazole + Ang II, respectively. Initial pHi were 6.98
0.02, 6.95 0.03, 7.00 0.02, and 6.98 0.03 for controls, Ang II,
econazole, and Aug II + econazole, respectively (NS for all comparisons).
The 30% decrease in dpHi/dt induced by high-dose Ang II alone was
reversed to a 24% increase when Aug IT was added in the presence of
econazole.
Ang 11-induced inhibition of the apical Na/H antiport activity is
suppressed by phospholipase A2 inhibitors
The effect of arachidonic acid and econazole suggested that the
inhibitory effect of high dose-Ang II could be mediated by the
hormone-induced activation of PLA2 and the subsequent cascade.
In order to test this possibility, we studied the effect of two PLA2
inhibitors on the decrease in dpHi/dt induced by i0 M Ang II.
When tubules were treated by either bromophenacyl bromide
(BPB, 6.6 106 M) or oleyloxyethyl phosphoryicholine (OPC, 5
i0' M) for two minutes before the addition of Ang II, the
inhibitory effect of Ang II was reversed and, instead, an increase
in dpHi/dt was observed (Table 5), leading to the conclusion that
inhibition of PLA2 unmasks the stimulating effect of Ang II.
Discussion
The present study, carried out in intact cells from freshly
isolated rat proximal tubule fragments, confirms that low dose
Ang II stimulates, whereas high dose Ang II inhibits, the apical
Na/H antiport activity, and add new information about the
relevant signaling pathways. Indeed, it clearly demonstrates that:
(1) the PKC pathway is the main signaling cascade involved in the
stimulating effect of low dose Ang II, whereas the PKA pathway
has no significant role; (2) the PLA2- and cytochromc P-450-
epoxygenase-dependent metabolites of arachidonic acid, mainly
5,6-EET, are involved in the inhibitory effect of high dose-Ang II
in the rat; (3) calcium-calmodulin-dependent kinase, which exerts
a tonic basal inhihition on the Na/H antiport activity, does not
play a significant role in the mediation of the effects of Ang 11.
After an intracellular acidification, no pHi recovery was ob-
served when pHi was recorded in a Na-free medium; addition of
30%
P<0.01
150
0
Lu
0
100
0I
a.
50 —
+ 24%
P<0.01
T
Control Ang II Econazole Econazole +
N=11 10-7M 105M ANGII
N=8 N=9 N=9
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Fig. 6. Effect of increasing concentrations of arachidonic acid on dpHi/dt.
Results are expressed as percent (± SE) of control values. Absolute values
were 0.434 0.036, 0.408 0.036, 0.350 0.042, 0.301 0.026, and
0.326 0.031 UpH/min for control, and 10- 12, 10b0, 10, and 10—6 M
arachidonic acid, respectively. Initial pHi were 6.86 0.03, 6.88 0.03,
6.85 0.03, 6.83 0.03, 6.87 0.03, 6.85 0.02, and 6.85 0.01 UpH
for control, 10— 12 10— 10 and 106 M arachidonic acid, econazole,
and econazole + arachidonic acid, respectively (NS for all comparisons).
The maximal inhibitory effect of arachidonic acid (10—8 M) was completely
blunted by econazole (10 M).
extracellular sodium elicited a prompt recovery of pHi (Fig. 1),
indicating that the pHi recovery is a Na-dependent process.
Amiloride (2 x iO M) markedly inhibited the rate of recovery of
intracellular pH after an acute cellular acidification (NH4 pre-
pulse). This result is in keeping with those obtained by others,
using the same methods of acute intracellular acidification and
intracellular pH measurement 21]. The inhibition by amiloride is
not complete, however, since 16% of the rate of pHi recovery
remains in the presence of amiloride. However, since initial pH
were different between controls and amiloride-treated cells, the
absolute values of dpHi/dt were not readily comparable. Never-
theless, since initial pH was lower in amiloride-treated cells than
in controls, it can be thought that the amiloride-induced inhibition
of pHi recovery is, if anything, under- rather than overestimated.
It was technically impossible to test a higher amiloride concentra-
tion in order to completely inhibit pHi recovery because of the
increasing quenching of the fluorescent signal. A significant
bicarbonate transport contributing to the acute changes in pHi
could be ruled out because all experiments have been conducted
in the absence of the C02/bicarhonate buffer system and pHi
recovery was not affected by the presence of io M SITS. Taken
together, these results establish that the proton transporter re-
sponsible for the pHi recovery under our experimental conditions
is a Na-dependent and amiloride-sensitive process, that is, a
sodium-proton antiport.
Further, we can argue that the Na/H antiport activity studied in
our preparation is located in the brush border membrane. First,
(9)
150
0
c)
0
100
I
a-
-a
50
— 30%
P<0.05
(10) (9)IT
— 38%
- P<0.02125
100
'75
50
NS
0 —12 —10 —8 —6 0 —8
Control Ang II 5,6 EET 5,6 EET
N=10 10-7M 106M ANGII
N=9 N=11 N=8
5 5 Fig. 7. Effect of arachidonic acid derivative 5,6-EET (10—6 M) on the high
dose Ang Il-induced decrease in dpHi/dt. Results are expressed as percent
(± SE) of control values. Absolute values were 0.378 0.048, 0.234
0.036, 0.264 0.024, and 0.266 0.031 UpH/min for controls, Ang II.
5,6-EET, and 5,6-EET + Ang II, respectively. Initial pHi were 6.73 0.03,
6.80 0.03, 6.74 0.03, and 6.77 0.03 for controls, Ang II, 5,6-EET,
and 5,6-EET + Ang II, respectively (NS for all comparisons). High dose
Ang II induced a 38% decrease in dpHi/dt whereas 5,6-EET induced a
30% decrease; no additive effect of 5,6-EET and Ang IT was observed.
Table 5. Effect of phospholipase A2 inhibitors BromoPhenacylBromide
(BPB, 6.6.10-6 vi) and OleyloxyethylPhosphorylCholine (OPC, 5 10 6
vi) on the high dose Ang TI-induced decrease in dpHi/dt
N Initial pH
dpHi/dt
UpH/min
Ang TI induced-
change in
dpHi/dt
BPB
Control 10 6.90 0.02 0.390 0.036
Ang II 9 6.89 0.03 0.264 0.030a —32%
BPB 10 6.86 0.02 0.342 0.036
BPB + Ang II 11 6.86 0.02 0.450 0.0306 32%
OPC
Control 7 6.83 0.02 0.355 0.032
Ang IT 9 6.83 0.02 0.263 0.043C —26%
OPC 8 6.86 0.02 0.335 0.032
OPC + Ang II 9 6.86 0.03 0.420 oo35 26%
-
P < 0.01 vs. control
<0.05 vs. BPB
P < 0.05 vs. control
d P < 0.05 vs. OPC
mRNA encoding for NHEI (the basolateral isoform of the Na/H
antiporter) is not detectable in Si and S2 segments from super-
ficial and most midcortical nephrons of rat kidney [22]. Because,
in our study, tubule segments were obtained from the outer
millimeter of the rat kidney cortex, the proportion of juxtamed-
ullary proximal tubules is very low and, subsequently, our prepa-
ration contains virtually no basolateral Na/H antiporter. Second, 2
ILM of the discriminant NHE inhibitor, HOE 694, do not affect the
rate of recovery of intracellular pH after acute addition of Na (10
mM). In this setting, however, NHE1, if present, should have been
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inhibited by —90% [18]. We can, therefore, conclude that, in
keeping with the absence of NHE1 mRNA in superficial proximal
tubules, there is, on a functional basis, no NHE1 antiport activity
in our preparation. In addition, both the prompt pHi recovery
which follows Na addition, and the inhibitory effect of amiloride
indicate that drugs gain access to the apical antiporter(s).
The stimulation of the apical Na/H antiport activity in proximal
tubule is a well-documented effect of low dose Ang IT, which has
been demonstrated either directly [21, 23—25] or indirectly by the
measurement of transepithelial sodium and bicarbonate fluxes [1,
2, 26]. Two different but not exclusive signaling pathways have
been proposed, the cyclic AMP-PKA and the phospholipase
C-PKC cascades. The role of the former pathway has been initially
suggested on the following data: most experiments have shown
that low dose of Ang II reduces cyclic AMP production by
proximal tubule cells in vivo and in vitro [4, 12, 13, 27]. More
importantly, an exogenous permeable form of cyclic AMP to
clamp intracellular cyclic AMP prevents Ang II from stimulating
HC01 absorption [4]. However, in OK cells in which the Ang
TI-induced stimulation of Na/H antiport is cyclic AMP-indepen-
dent, exogenous 8-bromo-cyclic AMP is able to prevent the effect
of the hormone, suggesting nonspecific effects [5]. The best
approach to demonstrate or exclude an involvement of the PKA
pathway in the mediation of the effect of low dose Ang II on apical
Na/H antiporter activity is to use a specific PKA inhibitor, an
experiment not previously reported for Ang II. In the present
experiments, the specific PKA inhibitor (Rp-8-CPT-cAMP) alone
did not affect the apical Na/H antiport activity, and low dose Ang
TI-induced stimulation of Na/H antiport was not affected by
pretreatment with Rp-8-CPT-cAMP. These results rule out a
significant role of PKA in the observed effect of low dose Ang II
on Na/H antiport activity.
The second signaling pathway possibly involved in the low dose
Ang IT-induced stimulation of Na/H antiport is the PLC-PKC
cascade. However its role remains controversial. In in vivo exper-
iments in rat proximal tubule, PKC inhibition either reduces or
abolishes the effects of low dose Ang IT, but the inhibitors used in
these studies [5, 6] may be not specific for PKC and may affect
multiple kinase pathways [8]. In addition Ang TI is not considered
to stimulate IPs production from results in rabbit proximal cells in
culture [9]. Tn the present study, low dose Ang II clearly stimulates
the apical Na/H antiport via PKC pathway. First pretreatment of
proximal tubules with three different PKC inhibitors (staurospor-
in sphingosine, and the specific one caiphostin) led to a com-
plete inhibition of the Tow dose Ang IT-induced stimulation of
Na/H antiport. In addition we found that a pertussis toxin-
sensitive GTP binding protein may he involved in the activation of
PKC by Ang II, as previously described in mesangial cells [28].
Second, our previous results demonstrate that Ang II stimulates
TPs production in freshly prepared rat proximal tubules through
AT1 receptor subtypes. Ang II induces a losartan-sensitive and
concentration-dependent early increase in IPs production with a
concomitant rise in cytosolic Ca2 mainly due to release from
intracellular stores [13]. Moreover, we recently showed that Ang
11 induces a dose dependent translocation of PKC isoforms in
brush border membranes of rat proximal tubules [29, 30]. Finally,
preliminary data from our group showed that the low dose Ang II(10 ' M) induced a PKC-dependent increase in protein phos-
phorylation in brush border membranes isolated from pretreated
rats, as compared to controls (unpublished results). Our results
are in discrepancy with those from one group which did not find
an increase in TPs production following Ang TI addition in rabbit
cultured proximal cells [9]. Although the explanation for this
difference is not readily apparent, species difference (rat vs.
rabbit) or, more probably, experimental difference (freshly pre-
pared proximal tubules or cultured cells on permeable supports
vs. cultured cells on plastic impermeable supports) could be one
factor. Indeed, in rat proximal tubule cells cultured in permeable
collagen-coated supports, Ang IT has been reported to increase
TPs production through AT1 receptor subtypes [31].
High dose Ang II is well known to inhibit transepithelial fluid,
sodium and HCO3 absorption in the proximal tubule [1, 2, 10,
32]. Thus in the present study the observed inhibition of the apical
Na/H antiport activity by high dose Ang II is a further confirma-
tion that the effects of Ang TI on the pH recovery are well
mediated by a modulation of the apical Na/H antiport activity.
Two main signaling pathways have been proposed to mediate this
effect: the calcium-calmodulin-dependent kinase [7, 10, 32] from
experiments in intact perfused proximal tubule, and the cyto-
chrome P-450-dependent metabolites of arachidonate from ex-
periments in rabbit proximal cells in culture [12]. Calcium cal-
modulin-dependent kinase has been shown to inhibit the Na/H
antiport activity in brush border membranes from proximal tu-
bules [11] and the apical Na/H antiporter of the cell line LLC-PK1
[33]. The inhibitory effect of high dose-Ang II in the proximal
Na/H antiport activity from rat kidney, was mimicked by the Ca2
ionophore ionomycin [10] and suppressed by TMB8 [7, 10], which
prevents the release of calcium from intracellular stores. There-
fore, it has been suggested (but not demonstrated) that the
increase in cytosolic Ca2 induced by high dose-Ang II inhibits
the absorption of HC03 in proximal tubule through the stimu-
lation of calcium calmodulin-dependent kinase [10]. In the
present study, we found that two different calcium calmodulin-
dependent kinase inhibitors, TFP and W-7, stimulated the Na/H
antiport activity, indicating that the calcium calmodulin-depen-
dent kinase exerts a basal tonic inhibition on the transporter(s).
However, high dose-Ang II equally reduced the Na/H antiport
activity, whether or not the calcium calmodulin-dependent kinase
was inhibited. These results indicate that the calcium calmodulin-
dependent kinase is not involved in the mediation of the high
dose-effects of Ang TI.
The findings of the present study with intact proximal tubules,
strongly support that the inhibitory effect of high dose Ang II is
mediated by an increased production of cytochrome P-45 0-epoxy-
genase-dependent metabolites of arachidonate through stimula-
tion of PLA2. First, the epoxygenase inhibitor econazole blocked
the high dose Aug Il-induced inhibition of the apical Na/H
antiport activity, and unmasked the PKC-dependent stimulation
of the antiport. Second, acute addition of arachidonate inhibited
the Na/H antiport in a dose-dependent manner, and the effect was
suppressed by econazole. Third, 5,6-EET, an important epoxide
produced by the rat proximal tubule cells [20], reproduced the
effect of high dose Ang IT, and the effect of 5,6-EET and high dose
Ang II were not additive. Finally, inhibition of PLA2 suppressed
the inhibitory effect of Mg II. These results are in agreement with
those obtained in rabbit proximal cells cultured on permeable
supports [12]. Whether the stimulation of PLA2 by Ang TI is a
direct effect of the hormone or an indirect consequence of the
activation of the PLC-dependent cascade remains to be deter-
mined.
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In summary, in intact rat proximal tubule cells in vitro, the
stimulation of PKC is the predominant (if not exclusive) mecha-
nism involved in the low dose Ang TI-induced increase in the
apical Na/H antiport activity. The stimulation of PLA2 with
subsequent rise in cytochrome P-450-dependent metabolites of
arachidonate is the main mechanism involved in the high dose
Ang Il-induced inhibition of the Na/H antiporter. In the presence
of high doses of Ang II, blocking the generation of cytochrome
P-450-dependent metabolites of arachidonate by econazole, un-
masks the increase in the Na/H antiport activity. When the
concentration of Ang II is progressively increased, the dose-
dependent increase in PLA2-induced generation of cytochrome
P-450 metabolites of arachidonate progressively counterbalances
the PKC-dependent stimulation of the Na/H antiporter(s), and,
eventually, leads to a net decrease in Na/H antiport activity.
Acknowledgments
This study was supported by grants from the Institut National de Ia
Sante et de Ia Recherche Médicale, and the Université Pierre et Marie
Curie. Part of this work was presented at the 26th Annual Meeting of the
American Society of Nephrology (Boston, November 1993). The authors
thank Dr. David G. Warnock, University of Alabama at Birmingham, for
fruitful discussions. We also thank Chanta! Nicolas for secretarial assis-
tance.
Reprint requests to Pascal Houillier, M.D., Service de Physiologic, Hôpital
Broussais, 96 rue Didot, 75674 Paris cédex 14, France.
References
1. HARRIS PJ, YOUNG JA: Dose-dependent stimulation and inhibition of
proximal tubular sodium reabsorption by angiotensin H in the rat
kidney. Pflugers Arch 367:295—297, 1977
2. SCHUSTER VL, KOKKO JP, JACOBSON HR: Angiotensin II directly
stimulates sodium transport in rabbit proximal convoluted tubules.
J Gun Invest 73:507—515, 1984
3. WANG T, CHAN YL: Mechanism of angiotensin II action on proximal
tubular transport. I Pharmacol Exp Ther 252:689—695, 1990
4. LIU F-Y, COGAN MG: Angiotensin II stimulates early proximal
bicarbonate absorption in the rat by decreasing cyclic adenosine
monophosphate. I Clin Invest 84:83—91, 1989
5. Co A, MILLER RT, ALPERN RJ, PREISIG PA: Angiotensin II
stimulation of Na-H antiporter activity is cAMP independent in OKP
cells. Am J Physiol 266(Cell Physiol 35):C1603—C1608, 1994
6. LIU F-Y, C0GAN MG: Role of protein kinase C in proximal bicarbon-
ate absorption and angiotensin signaling. Am J Physiol 258(Renal
Fluid Electrol Physiol 27):F927—F933, 1990
7. WANG T, CHAN YL: The role of phosphoinositide turnover in
mediating the biphasic effect of angiotensin II on renal tubular
transport. J Pharmacol Exp Ther 256:309—317, 1991
8. HIKADA H, KOBAYASHI R: Pharmacology of protein kinase inhibitors.
Annu Rev Pharmacol Toxicol 32:377—397, 1992
9. DOUGLAS JG, HOPFER U: Novel aspects of angiotensin receptors and
signal transduction in the kidney. Annu Rev Physiol 56:649—669, 1994
10. CHATSUDTHIPONG V, C IAN YL: Inhibitory effect of angiotcnsin II on
renal tubular transport. Am J Physiol 260(Renal Fluid Electrol Physiol
29):F340—F346, 1991
11. WEINMAN EJ, HANIIiY R, M0RELL G, YUAN N, STEPLOCK D, BUI G,
SHENOLIKAR S: Regulation of the renal Na -H exchanger by calcium
calmodulin-dependcnt multifunctionnal protein kinase II. Miner Elec-
trol Metab 18:35—39, 1992
12. ROMERO MF, HOPFER U, MADIItJN ZT, ZHOU W, DOUGLAS JG:
Angiotensin II actions in the rabbit proximal tubule. Renal Physiol
Biochem 14:199—207, 1991
13. POGGIOLI J, LAZAR G, HOUIIIIUR P, GARDIN JP, ACHARD JM,
PAILLARD M: Effects of angiotensin II and non peptide receptor
antagonists on transduction pathways in rat proximal tubule. Am J
Physiol 263(Cell Physiol 32):C750—C758, 1992
14. MEEZAN E, BRENDEL K, ULREICH J, CARLSON EC: Properties of a
pure metabolically active glomerular preparation from rat kidneys. I.
Isolation. J Phannacol Exp Ther 187:332—341, 1973
15. CHAMBREY R, PAILLARD M, PODEVIN RA: Enzymatic and functional
evidence for adaptation of the vacuolar H'-ATPase in proximal
tubule apical membranes from rats with chronic metabolic acidosis.
J Biol Chem 269:1—8, 1994
16. HACKENTHAI, E, AKTORIES K, JACOBS KI-1: Pertussis toxin attenuates
angiotensin TI-induced vasoconstriction and inhibition of renin re-
lease. Mol Cell Endocrinol 42:113—117, 1985
17. R0SSI NF, CHURCHILL PC, CHURCHILL MC: Pertussis toxin reverses
adenosinc receptor-mediated inhibition of renin secretion in rat renal
cortical slices. Life Sci 40:481—487, 1987
18. COUNILLON L, SCHOLZ W, LANG HJ, POUYSSEGUR J: Pharmacological
characterization of stably transfected Na7H antiporter isoforms
using amiloride analogs ans a new inhibitor exhibiting anti-ischemic
properties. Mol Pharmacol 44:1041—1045, 1993
19. NAGAMI GT: Effect of angiotensin II on ammonia production and
secretion by mouse proximal tubules perfused in vitro. I Gun Invest
89:925—931, 1992
20. OMATA K, ABRAHAM NG, SCHWATZMAN ML: Renal cytochrome
P-450-arachidonic acid metabolism: Localization and hormonal regu-
lation in SHR. Am J Physiol 262(Renal Fluid Electrol Metabol):F591—
F599, 1992
21. SACCOMANI G, MITCHELL KD, NAVAR LG: Angiotensin II stimulation
of Na/H exchange in proximal tubule cells. Am I Physiol 258(Renal
Fluid Electrol Physiol 27):F1188—F1195, 1990
22. KRAPF R, SoLIoz M: Na/H antiporter mRNA expression in single
nephron segments in rat kidney cortex. I Gun Invest 88:783—788, 1991
23. MORDUCHOwICZ GA, SHEIKH-HAMAD D, DWYER BE, STERN N, Jo
OD, YANAGAWA N: Angiotensin II directly increases rabbit renal
brush-border membrane sodium transport: Presence of local signal
transduction system. I Membr Biol 122:43—53, 1991
24. BLOCH RD, ZIK0S D, FISHER KA, SCHLEICHER L, OYAMA M, CHENG
J-C, SKOPICKI HA, SuKowsKI EJ, CRAGOE EJ JR, PETERSON DR:
Activation of proximal tubular Na'7H exchange by angiotensin II.
Am J Physiol 263(Renal Fluid Electrol Physiol 32):F135—F143, 1992
25. GEIBEL J, GIEBISCH G, BORON WF: Angiotensin II stimulates both
Na-H exchange and Na/HCO3 cotransport in the rabbit proxi-
mal tubule. Proc NatlAcad Sci USA 87:7917—7920, 1990
26. Lw F-Y, C0GAN MG: Angiotensin II stimulation of hydrogen ion
secretion in the rat early proximal tubule. Modes of action, mecha-
nism, and kinetics. J Gun Invest 82:601—607, 1988
27. WOODCOCK EA, JOHNSON Cl: Inhibition of adenylate cyclasc by
angiotensin II in rat renal cortex. Endocrinology 111:1687—1691, 1982
28. SCHLONDORFF D, SINGHAL P, HASSID A, SATRIANO JA, DE CANDIDO S:
Relationship of GTP-binding proteins, phospholipase C, PGE2 syn-
thesis in rat glomerular mesangial cells. Am J Physiol 256(Renal Fluid
Electrol Physiol 25):F171—F178, 1989
29. KARIM Z, DEFONTAINE N, PAILLARD M, P0GGI0LI J: Protein kinase C
isoforms in rat kidney proximal tubule: Acute effect of angiotensin II.
Am J Physiol 269(Cell Physiol 38):C134—C140, 1995
30. P0GGI0I,I J, KARIM Z, DEFONTAINE N, LAZAR G, B0DI I, PAIII.ARD M:
Protein kinase C (PKC) isozymes present in brush border membrane
vesicles (BBMV) isolated from rat kidney proximal tubules (PT) arc
activated by angiotensin H (All). (abstract) JAm Soc Nephrol 6:743,
1995
31. SCIIEJIING JR, HANSON AS, MARZEC R, LINAs SL: Cytoskclcton-
dependent endocytosis is required for apical type 1 angiotensin IT
receptor-mediated phospholipase C activation in cultured rat proxi-
mal tubule cells. J Clin Invest 90:2472—2480, 1992
32. DOMINGUUZ JH, SNOWDOWNE KW, FREUNDENRICH CC, BROWN T,
BORLE AB: Intracellular messenger for action of angiotenSin 11 on
fluid transport in rabbit proximal tubule.AmJPhysiol252(Renal Fluid
Electrol Physiol 21 ):F453—F428, 1987
33. BURNS KD, HOMMA T, HARRIS RC: Regulation of Na-H exchange
by ATP depletion and calmodulin antagonism in renal epithelial cells.
Am J Physiou 261(Renal Fluid Electrol Physiol 30):F607—F616, 1991
